Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (161-170 of 311) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of chronic thromboembolic pulmonary hypertensionHossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, et al.
Transplantation|March 19, 2008
Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive casesGerrit Grannas, Michael Neipp, Marius M Hoeper, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2017
Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertensionJawad Salman, Fabio Ius, Wiebke Sommer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionRaymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertensionMarc Humbert, Gérald Simonneau, David Pittrow, et al.
Genes|May 28, 2022
Reduction of <i>BMPR2</i> mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth, et al.
Heart (British Cardiac Society)|December 25, 2016
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertensionNick H Kim, Andrea M D'Armini, Friedrich Grimminger, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trialGérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
Academic Radiology|August 10, 2020
The Value of C-Arm Computed Tomography in Addition to Conventional Digital Subtraction Angiography in the Diagnostic Work-up of Patients with Suspected Chronic Thromboembolic Pulmonary Hypertension: An Update of 300 PatientsSabine K Maschke, Thomas Werncke, Lena S Becker, et al.
Pageof 32

Showing results (161-170 of 311) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of chronic thromboembolic pulmonary hypertensionHossein-Ardeschir Ghofrani, Andrea M D'Armini, Friedrich Grimminger, et al.
Transplantation|March 19, 2008
Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive casesGerrit Grannas, Michael Neipp, Marius M Hoeper, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2017
Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertensionJawad Salman, Fabio Ius, Wiebke Sommer, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionRaymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertensionMarc Humbert, Gérald Simonneau, David Pittrow, et al.
Genes|May 28, 2022
Reduction of <i>BMPR2</i> mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth, et al.
Heart (British Cardiac Society)|December 25, 2016
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertensionNick H Kim, Andrea M D'Armini, Friedrich Grimminger, et al.
European Journal of Immunology|March 30, 2026
Post-Acute Sequelae Patients with Severe COVID-19 History Show a Prolonged Inflammatory, Vascular Injury PatternLouisa Ruhl, Isabell Pink, Evgeny Chichelnitskiy, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trialGérald Simonneau, Andrea M D'Armini, Hossein-Ardeschir Ghofrani, et al.
Academic Radiology|August 10, 2020
The Value of C-Arm Computed Tomography in Addition to Conventional Digital Subtraction Angiography in the Diagnostic Work-up of Patients with Suspected Chronic Thromboembolic Pulmonary Hypertension: An Update of 300 PatientsSabine K Maschke, Thomas Werncke, Lena S Becker, et al.
Pageof 32